Recent constitutional and Federal Labour Law (FLL) reforms in Mexico have reframed equal pay as a structural obligation to reduce the gender pay gap, moving beyond its traditional role as an individual anti-discrimination guarantee. This article examines the implications of this shift and the emerging pay-transparency proposals which may soon reshape employer compliance expectations.
Released on Apr 21, 2026
Directive (EU) 2023/970 on pay transparency should not be viewed merely as a new compliance obligation. If properly implemented, it offers companies an opportunity to review remuneration systems, organisational structures and internal procedures, improving both regulatory compliance and organisational efficiency.
Released on Apr 21, 2026
Putin’s invasion of Ukraine has prompted international legal service providers to shut down operations in Russia, marking a palpable shift in the sector. If law firms do not re-examine their ethical standards and the moral standing of their clients, regulators may do it for them.
Released on Apr 25, 2022
Dr Reddy’s Laboratories Ltd (Dr Reddy’s), a large Indian pharmaceutical company, has American Depositary Receipts (ADRs) listed on the New York Stock Exchange and is an ‘issuer’ under the Foreign Corrupt Practices Act, 1977 (FCPA). In November 2020, Dr Reddy’s made a filing before the US Securities and Exchange Commission (SEC) stating that it had begun an investigation into an anonymous complaint alleging breaches of anti-corruption laws, specifically the FCPA.
Released on Oct 29, 2021
The article provides an overview of the latest changes and law-enforcement practice in combating corruption in Ukraine.
Released on Oct 29, 2021